Flagship Pioneering operates as a biotechnology company focused on inventing platforms and building companies that aim to transform human health and sustainability. The company's main offerings include the creation of scientific ventures and the development of platforms that lead to innovative products in...
风投公司FlagshipPioneering与辉瑞达成合作加速创新药物开发:美国生命科学风险投资公司FlagshipPioneering和辉瑞7月18日宣布,两家公司已合作创建新的创新药物通道。根据新协议的条款,Flagshi... 快讯正文 风投公司FlagshipPioneering与辉瑞达成合作加速创新药物开发:美国生命科学风险投资公司FlagshipPioneering和辉瑞7月18日宣布,两...
Flagship Pioneering Company InformationChange The World Updated:10/11/21 Country:U.S. Headquarters:Cambridge, Mass. Industry:Diversified Financials CEO:Noubar Afeyan Website:https://www.FlagshipPioneering.com Ticker: Company type:Private Revenues ($M): Profits ($M): Market value ($M): Number of...
智通财经APP获悉,葛兰素史克(GSK.US)和顶级风投机构Flagship Pioneering Inc.达成合作,将开发多达10种新药,这笔交易可能会向这家生物技术风投支持的公司支付逾70亿美元。 根据周一的一份声明,葛兰素史克和Flagship将共同提供高达1.5亿美元的预付款,用于探索新的呼吸和免疫治疗方法。如果这10种药物达到所有的开发和商业里...
I would say just one last thing. The reason we use the word “pioneering” is that there’s a first-in-kind character to what we do. That potentially makes it scale-free to the extent that there are always new things to explore and new places to go. Opportunities will constantl...
Quotient Therapeutics, co-located in Cambridge, Mass. and Cambridge, U.K., will receive $50 million over two years from Flagship to study somatic genomics with an eye to finding new targets for gene therapies.
Life Before Moderna and Life After. Flagship Pioneering is the biotech venture capital firm best-known for funding Moderna, a startup that went from also-ran to household name after it created a highly effective COVID-19 vaccine based on its mRNA technology. Moderna has sold and distributed bi...
(Sana) (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the pricing of its upsized initial public offering of 23,500,000 shares of its common stock at a public offering price of $25.00 per share. All of the shares of common stock...
Flagship Pioneering announced that former FDA commissioner Dr. Stephen Hahn will lead its Preemptive Medicine & Health Security initiative. A “bioinnovation platform company,” Flagship Pioneering has originated and fostered more than 100 scientific ventures totaling more than $90 billion in aggregate va...
Evelo BiosciencesFlagship PioneeringBiotech graveyardmicrobiome Evelo Biosciences has tasked Rock Creek Advisors with helping find deals for its assets. (Liudmila Chernetska/Getty Images) Evelo Biosciences is dissolving. One month after starting a search for strategic alternatives, the Flagship ...